![Walgreens Boots Alliance, Inc. Website](https://cdn.finchat.io/93624.png)
Walgreens Boots Alliance, Inc.
NasdaqGS-WBA
Company Overview
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Name
Walgreens Boots Alliance, Inc.
CEO
Mr. Timothy C. Wentworth
Website
www.walgreensbootsalliance.com
Sector
Consumer Staples Distribution and Retail
Year Founded
1909
Profile
Market Cap
$7,570.92M
EV
$42.31B
Shares Out
863.28M
Revenue
$145.53B
Employees
268,500
Margins
Gross
18.38%
EBITDA
2.72%
Operating
1.29%
Pre-Tax
-9.32%
Net
-3.99%
FCF
-0.61%
Returns (5Yr Avg)
ROA
0.99%
ROTA
3.55%
ROE
2.81%
ROCE
5.4%
ROIC
3.45%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$12.81
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$711M
Net Debt
$32.95B
Debt/Equity
2.18
EBIT/Interest
3.54
Growth (CAGR)
Rev 3Yr
4.2%
Rev 5Yr
1.31%
Rev 10Yr
6.81%
Dil EPS 3Yr
36.65%
Dil EPS 5Yr
5.69%
Dil EPS 10Yr
8.76%
Rev Fwd 2Yr
2.98%
EBITDA Fwd 2Yr
-11.11%
EPS Fwd 2Yr
-28.11%
EPS LT Growth Est
-24.69%
Dividends
Yield
—
Payout
-21.68%
DPS
$1.46
DPS Growth 3Yr
-7.92%
DPS Growth 5Yr
-3.67%
DPS Growth 10Yr
1.48%
DPS Growth Fwd 2Yr
1.51%